Testing a digital tool for Parkinson's symptoms
Part of Brain & nervous system clinical trials.
This study tests a digital tool (NMS Assist) to help people with Parkinson's and their caregivers track and manage non-motor symptoms like mood, sleep, and thinking changes. Participation takes place from home using a smartphone or tablet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a smartphone or tablet and can go online
- You speak and understand English well
- You have been diagnosed with Parkinson's – or you are the caregiver of someone who has
- You are not living in a care home or nursing home (if you have Parkinson's)
- You can walk on your own (if you have Parkinson's)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital app that tracks speech and health changes. It is open to people with certain neurological conditions, their caregivers, and healthy volunteers.
This trial tests a new management approach using remote monitoring via smartphone or tablet to help people with Parkinson's better manage their condition. It aims to see if this tool improves care compared to standard follow-up.
This trial uses new technology (like sensors or apps) to help diagnose and monitor Parkinson's disease early. Researchers want to see if a simple, widespread healthcare service model can improve care. Both people with Parkinson's and healthy volunteers are needed.
This trial uses smartphone sensors to track movement in people with early-to-mild Parkinson's disease. It aims to find digital markers that help doctors better monitor symptoms and adjust treatments.
This trial tests a 8-week online program to help people with Parkinson's disease improve their daily activities through behavioral strategies. You can join from home using a computer, tablet, or phone with internet.
This trial tests a remote way to assess people newly diagnosed with Parkinson's disease, to help monitor their condition and guide care.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.